Urolithin A (Mitopure)

The VerdictLOW CONVICTION

It has real human trials, but they show a modest muscle boost in older adults, not anti-aging.

If you bought a pomegranate or "pomegranate extract" supplement expecting the urolithin A benefit, stop. Only about 1 in 8 people make meaningful urolithin A from food. If you actually want it, the synthetic form (Mitopure) is the only reliable route, and it's a muscle-endurance aid for aging adults, not an anti-aging pill.

It's the rare longevity supplement with real placebo-controlled human trials, and they show a modest muscle strength/endurance gain in middle-aged and older adults.
Both flagship studies actually missed their main goal and the company that sells it ran most of them, so the headline is softer than the marketing.

That's the general answer. Your stack is different.

Check your whole stack

If you bought a pomegranate or "pomegranate extract" supplement expecting the urolithin A benefit, stop. Only about 1 in 8 people make meaningful urolithin A from food.

If you actually want it, the synthetic form (Mitopure) is the only reliable route, and the evidence makes it a muscle-endurance aid for aging adults, not an anti-aging pill.

Takes 30 seconds. Check what you already own.

The Protocol

Who	Dose	Timing	Form	Loading
Middle-aged adults (muscle goal)	500–1000 mg/day	With food	Synthetic UA (Mitopure)	None
Older adults (65–90)	500–1000 mg/day	With food	Synthetic UA	None
Trained / elite athletes	No effective dose shown	—	—	None

Forms compared

Synthetic UA (Mitopure)

Consistent plasma levels

The only form with human data. Microbiome-independent.

~£50–90+/month

Pomegranate / walnuts (food)

~12% are efficient producers

Works only for the minority with the right gut bacteria.

Low (food)

"Pomegranate extract" caps

Delivers precursor, not UA

Not a reliable UA source. Conversion still microbiome-gated.

Low–moderate

Absorption: Taken with food in the trials. The key fact is not a cofactor, it's your gut bacteria. If you rely on food, your microbiome sets your dose, and for most people that dose is near zero. The synthetic form removes that lottery.

Safety & Interactions

Tolerability

Well tolerated at 500–1000 mg/day for up to 4 months. Adverse events were mild-to-moderate and comparable to placebo across trials.

Drug interactions

None established. No human drug-interaction studies exist. UA is processed into glucuronide and sulfate forms; interactions are simply uncharacterized.

Who should avoid it

Pregnancy, lactation, and children: not studied, no safety data. Heart-failure patients should not expect cardiac benefit (the one trial was null).

Upper limit: None established. Longest human exposure is roughly 4 months at ≤1000 mg/day with a favourable safety profile. Long-term safety is unstudied.

Conviction: LOW–MODERATE

Real human trials put it ahead of most longevity supplements, but the muscle benefit rests on secondary endpoints in manufacturer-funded studies, and the longevity claim has zero human outcome data.

What would change this verdict?

An independent (non-manufacturer-funded), double-blind, placebo-controlled trial of 200+ middle-aged or older adults, 6+ months, at 1000mg/day, with a pre-registered functional goal the study is actually powered to hit (like gait speed or chair-stand power), showing a real between-group effect, would move muscle conviction to HIGH. Any trial measuring a hard outcome (falls, disability, age-related muscle loss, mortality) would be the first real test of the longevity claim, which currently has none.

Worth Your Money?

Weekly cost~£12–£22 per week (about £50–90+ per month) at the synthetic 500–1000mg dose.

Worth it ifYou're a middle-aged or older adult who wants a modest muscle-endurance edge and you've already got training, protein, and sleep handled.

Lower priority ifYou're chasing longevity or performance. Your next £60 is almost certainly better spent on a coach, more protein, or fixing your sleep than on this.

Conditional Value

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week, with the receipts. Free.

Join The Verdict — free

Claims vs Evidence — See What the Research Found

What People Claim

"Urolithin A renews your aging mitochondria. It boosts cellular energy, builds muscle longevity, fights aging, and turns back your biological clock. And it comes from pomegranate, so eating more is the natural route to the same benefit."

That's the pitch, and the underlying biology is real: as you age, your cells stop clearing out damaged mitochondria, and UA switches that cleanup back on. The leap is from "switches on cleanup" to "anti-aging." The honest version, which the company's own science supports, is narrower: UA has genuine placebo-controlled human trials (more than NMN, resveratrol, or spermidine can say), and the question is simply what those trials found.

What the Evidence Actually Shows

Claim	Strength	What the data shows
Muscle strength / endurance (aging adults)	MODERATE	~+12% strength and better endurance, but as secondary endpoints (Singh 2022; Andreux 2022; D'Amico 2024 SR)
Mitochondrial / inflammation biomarkers	MODERATE	Lower acylcarnitines and CRP, more mitophagy gene expression. A readout, not an outcome.
Maximal ATP / mitochondrial biogenesis / physical function	LOW-NULL	Directly measured and did not improve (D'Amico 2024 SR; Andreux 2022)
Reliable delivery vs food/microbiome	STRONG	Only ~12% produce UA from food; 500mg synthetic gives consistent levels (Tomás-Barberán 2022, N=100)
Immune-aging (T-cell phenotypes)	EMERGING	Expanded naive-like CD8+ cells in a 4-week trial (Liu 2025, N=50). Immune cells, not clinical outcome.
Performance in trained / elite athletes	LOW-NULL	1RM gains not significant (Liu 2024, N=20); runner trial in elite athletes
Heart-failure / cardiac function	LOW-NULL	No effect on heart-function measures (Tabrizi 2024, N=10)
Longevity / lifespan / mortality	NONE	Zero human outcome data. "Geroprotective" is mechanism and biomarker framing.

The Full Picture — Mechanism, Debate & Nuance

How It Works

You don't eat urolithin A directly. Your gut bacteria make it when they break down the polyphenols in pomegranate, walnuts, and some berries. The problem: the bacteria that can do this aren't in everyone's gut. People split into high producers, variable producers, and non-producers, and most convert very little. That's why eating pomegranate is an unreliable route, and why the supplement exists.

Once absorbed, UA's signature action is mitophagy: the selective recycling of worn-out mitochondria. Clear the broken units, the theory goes, and the surviving pool runs cleaner, inflammation drops, and aging muscle holds more of its function. In humans you see lower acylcarnitines (more efficient fat burning), lower CRP (less inflammation), and more mitophagy gene activity in muscle.

Here's the catch the marketing skips. Across the pooled human data, UA moved those quality signals but did not change maximal ATP production, mitochondrial biogenesis, or dynamics. The signature improved. The mitochondria's measured energy output did not.

The Debate

Did the flagship trials actually work?

Singh 2022 + Andreux 2022: muscle strength up ~12%, endurance improved.

Both trials MISSED their pre-registered primary endpoints (peak power; 6-min walk + ATP).

The signal lives in secondary outcomes. Positive secondaries after a negative primary are hypothesis-generating, not confirmatory.

Why does it work in older adults but not athletes?

Aging adults: a measurable muscle-endurance benefit.

Trained athletes and elite runners: no demonstrated benefit.

Baseline matters. UA acts on declining mitochondria. Young trained muscle has little deficit to rescue, the same ceiling seen with CoQ10 and cordyceps.

Honest Limitations

Manufacturer-dominated evidence

The pivotal efficacy and safety trials are sponsored by or authored by Amazentis, which sells the only form tested (Mitopure). The independent trials (athletes, heart failure) were null. Treat the effect size as a ceiling, not a floor. This is the CoQ10/PQQ pattern: the company that profits ran the studies that matter.

Primary-endpoint misses sold as wins

Both flagship trials failed their pre-registered primary endpoints. A consumer reads "clinically proven to improve strength." The trial reads "did not improve peak power, but a secondary strength measure rose."

Biomarker-to-outcome gap

The "mitophagy fights aging" story is built on gene expression and blood markers, while the directly measured functional output and physical function were null. UA changes the readouts of mitochondrial quality without yet proving it changes what your mitochondria do for you.

The Nuance

Who benefits most: middle-aged and older adults seeking a modest muscle edge, and anyone who wants reliable UA exposure and isn't a dietary producer (most people). For the delivery question, synthetic UA is genuinely the only dependable route.

What doesn't work

"Pomegranate juice or extract gives you urolithin A." For roughly 88% of people it does not, because they lack the gut bacteria. This is the single most important consumer fact.
"It boosts your cellular energy." The directly measured maximal ATP production did not improve.
"Clinically proven to make you stronger and fitter." The flagship trials missed their primary endpoints; those figures are secondary.
"It's an anti-aging supplement." No human study has measured lifespan, mortality, falls, disability, or muscle-loss incidence.

Food-first reality: there's no reliable food alternative for non-producers. Pomegranate and walnuts only help the minority with the right microbiome.

Sources

D'Amico D, et al. (2024). Targeting aging with urolithin A in humans: A systematic review. Ageing Research Reviews. 5 trials, N≈250. Increased muscle strength/endurance; NO effect on maximal ATP production, biogenesis, physical function, or cardiovascular outcomes.
Singh A, et al. (2022). Urolithin A improves muscle strength, exercise performance, and mitochondrial health. Cell Reports Medicine. RCT, middle-aged adults, 500 & 1000 mg/day × 4mo. Primary (peak power) not significant; strength ~+12% (secondary). Amazentis-funded.
Andreux PA, et al. (2022). Urolithin A on muscle endurance and mitochondrial health in older adults. JAMA Network Open. RCT, 65–90y, N=66. Primary (6-min walk + ATP) not significant; endurance improved (secondary). Amazentis-funded.
Andreux PA, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial health in humans. Nature Metabolism. First-in-human; favourable safety, bioavailable. Amazentis-funded.
Tomás-Barberán FA, et al. (2022). Direct supplementation with urolithin A overcomes microbiome and dietary variability. European Journal of Clinical Nutrition. N=100. Only ~12% efficient producers; 500mg gives consistent plasma levels.
Liu S, et al. (2025). Urolithin A and age-related immune decline: a randomized, placebo-controlled trial. Nature Aging. N=50, 1000 mg/day × 4wk. Expanded naive-like CD8+ cells (immunophenotype).
Liu Y, et al. (2024). Urolithin A in resistance-trained male athletes. J Int Soc Sports Nutr. N=20, 1000 mg/day × 8wk. 1RM gains not significant (bench p=0.051).
Tabrizi R, et al. (2024). Urolithin A in heart failure with reduced ejection fraction. Reviews on Recent Clinical Trials. N=10 crossover. No effect on heart-function measures.